253 related articles for article (PubMed ID: 37607832)
1. Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17.
Hu H; Ho DHH; Tan DS; MacCarthy CM; Yu CH; Weng M; Schöler HR; Jauch R
Nucleic Acids Res; 2023 Sep; 51(17):8934-8956. PubMed ID: 37607832
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17.
Srivastava Y; Tan DS; Malik V; Weng M; Javed A; Cojocaru V; Wu G; Veerapandian V; Cheung LWT; Jauch R
FEBS J; 2020 Jan; 287(1):122-144. PubMed ID: 31569299
[TBL] [Abstract][Full Text] [Related]
3. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA.
Jauch R; Aksoy I; Hutchins AP; Ng CK; Tian XF; Chen J; Palasingam P; Robson P; Stanton LW; Kolatkar PR
Stem Cells; 2011 Jun; 29(6):940-51. PubMed ID: 21472822
[TBL] [Abstract][Full Text] [Related]
4. Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming.
Aksoy I; Jauch R; Eras V; Chng WB; Chen J; Divakar U; Ng CK; Kolatkar PR; Stanton LW
Stem Cells; 2013 Dec; 31(12):2632-46. PubMed ID: 23963638
[TBL] [Abstract][Full Text] [Related]
5. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate.
Stefanovic S; Abboud N; Désilets S; Nury D; Cowan C; Pucéat M
J Cell Biol; 2009 Sep; 186(5):665-73. PubMed ID: 19736317
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the SOX-dependent genomic redistribution of OCT4 in stem cell differentiation.
Merino F; Ng CKL; Veerapandian V; Schöler HR; Jauch R; Cojocaru V
Structure; 2014 Sep; 22(9):1274-1286. PubMed ID: 25126959
[TBL] [Abstract][Full Text] [Related]
7. A role for mitotic bookmarking of SOX2 in pluripotency and differentiation.
Deluz C; Friman ET; Strebinger D; Benke A; Raccaud M; Callegari A; Leleu M; Manley S; Suter DM
Genes Dev; 2016 Nov; 30(22):2538-2550. PubMed ID: 27920086
[TBL] [Abstract][Full Text] [Related]
8. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
9. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
[TBL] [Abstract][Full Text] [Related]
10. Highly cooperative chimeric super-SOX induces naive pluripotency across species.
MacCarthy CM; Wu G; Malik V; Menuchin-Lasowski Y; Velychko T; Keshet G; Fan R; Bedzhov I; Church GM; Jauch R; Cojocaru V; Schöler HR; Velychko S
Cell Stem Cell; 2024 Jan; 31(1):127-147.e9. PubMed ID: 38141611
[TBL] [Abstract][Full Text] [Related]
11. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm.
Aksoy I; Jauch R; Chen J; Dyla M; Divakar U; Bogu GK; Teo R; Leng Ng CK; Herath W; Lili S; Hutchins AP; Robson P; Kolatkar PR; Stanton LW
EMBO J; 2013 Apr; 32(7):938-53. PubMed ID: 23474895
[TBL] [Abstract][Full Text] [Related]
12. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency.
Tapia N; MacCarthy C; Esch D; Gabriele Marthaler A; Tiemann U; Araúzo-Bravo MJ; Jauch R; Cojocaru V; Schöler HR
Sci Rep; 2015 Aug; 5():13533. PubMed ID: 26314899
[TBL] [Abstract][Full Text] [Related]
14. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2.
Malik V; Glaser LV; Zimmer D; Velychko S; Weng M; Holzner M; Arend M; Chen Y; Srivastava Y; Veerapandian V; Shah Z; Esteban MA; Wang H; Chen J; Schöler HR; Hutchins AP; Meijsing SH; Pott S; Jauch R
Nat Commun; 2019 Aug; 10(1):3477. PubMed ID: 31375664
[TBL] [Abstract][Full Text] [Related]
15. SOX17 in cellular reprogramming and cancer.
Tan DS; Holzner M; Weng M; Srivastava Y; Jauch R
Semin Cancer Biol; 2020 Dec; 67(Pt 1):65-73. PubMed ID: 31419525
[TBL] [Abstract][Full Text] [Related]
16. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency.
Liu P; Chen M; Liu Y; Qi LS; Ding S
Cell Stem Cell; 2018 Feb; 22(2):252-261.e4. PubMed ID: 29358044
[TBL] [Abstract][Full Text] [Related]
18. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
19. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
20. Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.
Soufi A; Zaret KS
Cell Cycle; 2013 May; 12(10):1487-91. PubMed ID: 23603987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
